• About
  • Subscribe
  • Advertise
  • Contact
Tuesday, March 17, 2026
Newsletter
SUBSCRIBE
  • Latest News
  • All Sections
    • Ophthalmic insights
      • Policy & regulation
      • Company updates & acquisitions
      • Research
      • Clinical trials
      • Workforce
      • Product approvals
      • Conferences
      • Opinion
      • Indigenous eye health
      • Retail
    • Eye disease
      • Dry eye
      • Myopia
      • Cataract
      • Glaucoma
      • Macular disease – AMD
      • Diabetic eye disease
      • Inherited retinal disease
      • Corneal disease
      • Presbyopia
      • Eye infections
    • Ophthalmic Careers
      • New appointments
      • Industry profiles
      • Graduates
    • Ophthalmic organisations
      • Regulators
      • Optometry networks
      • Private ophthalmology clinics
      • Associations
      • Patient support bodies
      • Eye research institutions
      • Optometry schools
      • Optical Dispensing trainers
      • Medical schools
      • RANZCO
  • Features
    • Report
    • Soapbox
  • Ophthalmic education
    • CPD – Optometry
    • Optical Dispensing
    • Orthoptics Australia
    • Practice management
  • Products
    • Ophthalmic Treatments
      • Ophthalmic lenses
      • Lens treatments
      • Myopia interventions
      • Light-based therapy
      • Minimally invasive glaucoma surgery (MIGS)
      • Gene therapy
      • Laser treatments
      • Supplements
      • Eyewear & frames
      • Behavioural optometry/vision training
      • Contact lenses
      • Anti-VEGF
      • Intraocular lenses (IOLs)
      • Pharmaceuticals & consumables
    • Ophthalmic equipment & diagnostics
      • Biometry – axial length
      • Perimetry & visual fields
      • OCT
      • Phoropter
      • Autorefractor
      • Tonometry
      • Topography
      • Multimodal imaging
      • Retinal imaging
      • Anterior segment imaging
      • Software & data management
      • Microscopes
      • Slit lamps
      • Lens edging
      • Stands, chairs and tables
      • Ultrasound
      • Dry eye diagnostics
      • Low vision aids
  • Research
  • Classifieds
No Results
View All Results
  • Latest News
  • All Sections
    • Ophthalmic insights
      • Policy & regulation
      • Company updates & acquisitions
      • Research
      • Clinical trials
      • Workforce
      • Product approvals
      • Conferences
      • Opinion
      • Indigenous eye health
      • Retail
    • Eye disease
      • Dry eye
      • Myopia
      • Cataract
      • Glaucoma
      • Macular disease – AMD
      • Diabetic eye disease
      • Inherited retinal disease
      • Corneal disease
      • Presbyopia
      • Eye infections
    • Ophthalmic Careers
      • New appointments
      • Industry profiles
      • Graduates
    • Ophthalmic organisations
      • Regulators
      • Optometry networks
      • Private ophthalmology clinics
      • Associations
      • Patient support bodies
      • Eye research institutions
      • Optometry schools
      • Optical Dispensing trainers
      • Medical schools
      • RANZCO
  • Features
    • Report
    • Soapbox
  • Ophthalmic education
    • CPD – Optometry
    • Optical Dispensing
    • Orthoptics Australia
    • Practice management
  • Products
    • Ophthalmic Treatments
      • Ophthalmic lenses
      • Lens treatments
      • Myopia interventions
      • Light-based therapy
      • Minimally invasive glaucoma surgery (MIGS)
      • Gene therapy
      • Laser treatments
      • Supplements
      • Eyewear & frames
      • Behavioural optometry/vision training
      • Contact lenses
      • Anti-VEGF
      • Intraocular lenses (IOLs)
      • Pharmaceuticals & consumables
    • Ophthalmic equipment & diagnostics
      • Biometry – axial length
      • Perimetry & visual fields
      • OCT
      • Phoropter
      • Autorefractor
      • Tonometry
      • Topography
      • Multimodal imaging
      • Retinal imaging
      • Anterior segment imaging
      • Software & data management
      • Microscopes
      • Slit lamps
      • Lens edging
      • Stands, chairs and tables
      • Ultrasound
      • Dry eye diagnostics
      • Low vision aids
  • Research
  • Classifieds
No Results
View All Results
Home Local

New technology solutions for light sensitive patients

by Staff Writer
February 9, 2022
in Lenses, Local, News, Products
Reading Time: 3 mins read
A A
Transitions XTRActive New Generation and Transitions XTRActive Polarized for light sensitive spectacle wearers.

Transitions XTRActive New Generation and Transitions XTRActive Polarized for light sensitive spectacle wearers.

Share on FacebookShare on Twitter

Two new extra dark photochromic technologies are now available in the Essilor and OSA lens range for spectacle wearers who struggle with light sensitivity.

Transitions XTRActive New Generation and Transitions XTRActive Polarized have been recently launched and come in response to Transitions Optical research showing that nine out of 10 spec wearers declare they are ‘light sensitive’, with three out of 10 stating they are ‘very light sensitive’.1

Research from Transitions Optical showed that very light sensitive wearers experience painful symptoms 2.2 times more often than others. At times even low light intensity from everyday environments – such as artificial lighting in the office or supermarket – can bother them.

Their difficulties intensify as the light level increases and they can experience symptoms like itchy eyes, headaches and eyestrain2.

Transitions XTRActive New Generation and Transitions XTRActive Polarized have been developed for these very light sensitive wearers.

The Transitions XTRActive range, is clear to extra dark and clear to polarised, delivering extra light protection for wearers wanting darker lenses and who are frequently exposed to bright or reflected light, and who are very light sensitive.

Both lenses are clear indoors and extra dark outdoors – even in hot temperatures. They also darken in the car, filter blue light and block 100% UVA and UVB. Based on the latest Transitions technology they now are even faster to fade back, Essilor stated.

Transitions XTRActive New Generation, in standard tests conducted by Transitions Optical was the only photochromic lens to reach category 3 darkness in hot temperatures and category 2 darkness in the car.  Available in grey, brown and graphite green colours.

Transitions XTRActive Polarized is the only clear to dark dynamic polarised photochromic lens with up to 90% effective polarisation.  Available in grey only.

References 

  1. Baillet G., Granger B., How Transitions® lenses filter harmful blue light, Points de Vue, International Review of Ophthalmic Optics, online publication, March 2016
  2. Transitions Optical, Quality of Vision and Vision Experience Test In Real Life situations (Life Wearer Testing), France, Eurosyn, Q3 2020, N=148 Transitions Optical, Wearers Survey, Value Proposition & Light Management, U.S., 2019, N=134 (self-declared very light sensitive to light) *caution: small sample size
  3. Based on tests across materials on grey lenses @ 23°C, using ISO 12312-1 standard
  4. Clear to extra dark photochromic category. Tests across polycarbonate and 1.5 grey lenses at 35°C achieving 18%T using Transitions Optical standard testing method.
  5. Clear to extra dark photochromic category. Polycarbonate and 1.5 grey lenses tested at 23°C behind the windshield achieving between 18%T and 43%T.

More reading

Transitions breakthrough polarised lens lauded at Silmo Paris

EssilorLuxottica completes GrandVision deal

Luxottica’s premiumisation plans

Tags: AustraliaEssilorlenslight sensitiveTransitionsTransitions XTRActive new generationTransitions XTRActive Polarized

Related Posts

Aussie Rules players in Darwin are being hit by mystery eye infections. Image: AlazySM/stock.adobe.com.

Aussie Rules players struck down by mystery eye infections

by Staff Writer
March 17, 2026

Eyecare professionals in the Northern Territory are scratching their heads over an outbreak of eye infection that has hit dozens...

Optos ultra-widefield imaging will be on show at events in Western Australia and NSW. Image: Prime Creative Media.

Optos technology on show in upcoming events

by Staff Writer
March 16, 2026

Optos is encouraging eyecare professionals serious about advancing patient care and staying ahead in eye health technology to visit its...

The eye drops can quickly relieve tired, red eyes. Image: LimeSky/stock.adobe.com.

B+L announces launch of Lumify eye drops in Australia

by Staff Writer
March 16, 2026

Bausch + Lomb (B+L) has announced the Australian launch of Lumify redness reliever eye drops in April. The Lumify range...

Join our newsletter

View our privacy policy, collection notice and terms and conditions to understand how we use your personal information.

Insight has been the leading industry publication in Australia for more than 40 years. This longevity is largely due to our ability to consistently deliver accurate and independent news relevant to all ophthalmic professionals and their supporting industry.

Subscribe to our newsletter

View our privacy policy, collection notice and terms and conditions to understand how we use your personal information.

About Insight

  • About
  • Advertise
  • Subscribe
  • Contact
  • Terms & Conditions
  • Privacy Collection Notice
  • Privacy Policy

Popular Topics

  • Business
  • Feature
  • Research
  • Technology
  • Therapies
  • Classifieds

© 2026 All Rights Reserved. All content published on this site is the property of Prime Creative Media. Unauthorised reproduction is prohibited

No Results
View All Results
NEWSLETTER
SUBSCRIBE
  • Latest News
  • All Sections
    • Ophthalmic insights
      • Policy & regulation
      • Company updates & acquisitions
      • Research
      • Clinical trials
      • Workforce
      • Product approvals
      • Conferences
      • Opinion
      • Indigenous eye health
      • Retail
    • Eye disease
      • Dry eye
      • Myopia
      • Cataract
      • Glaucoma
      • Macular disease – AMD
      • Diabetic eye disease
      • Inherited retinal disease
      • Corneal disease
      • Presbyopia
      • Eye infections
    • Ophthalmic Careers
      • New appointments
      • Industry profiles
      • Graduates
    • Ophthalmic organisations
      • Regulators
      • Optometry networks
      • Private ophthalmology clinics
      • Associations
      • Patient support bodies
      • Eye research institutions
      • Optometry schools
      • Optical Dispensing trainers
      • Medical schools
      • RANZCO
  • Features
    • Report
    • Soapbox
  • Ophthalmic education
    • CPD – Optometry
    • Optical Dispensing
    • Orthoptics Australia
    • Practice management
  • Products
    • Ophthalmic Treatments
      • Ophthalmic lenses
      • Lens treatments
      • Myopia interventions
      • Light-based therapy
      • Minimally invasive glaucoma surgery (MIGS)
      • Gene therapy
      • Laser treatments
      • Supplements
      • Eyewear & frames
      • Behavioural optometry/vision training
      • Contact lenses
      • Anti-VEGF
      • Intraocular lenses (IOLs)
      • Pharmaceuticals & consumables
    • Ophthalmic equipment & diagnostics
      • Biometry – axial length
      • Perimetry & visual fields
      • OCT
      • Phoropter
      • Autorefractor
      • Tonometry
      • Topography
      • Multimodal imaging
      • Retinal imaging
      • Anterior segment imaging
      • Software & data management
      • Microscopes
      • Slit lamps
      • Lens edging
      • Stands, chairs and tables
      • Ultrasound
      • Dry eye diagnostics
      • Low vision aids
  • Research
  • Classifieds
  • About Us
  • Advertise with Insight
  • Subscribe
  • Contact Insight

© 2026 All Rights Reserved. All content published on this site is the property of Prime Creative Media. Unauthorised reproduction is prohibited